Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. scores highest on Anchor (62) and lowest on Nitro (31). Its PosiPenta is 44.32 out of 100, around the middle of similar companies.
On the Penta Grid this week, Allogene Therapeutics, Inc. is Grid #401 of 837 in the Healthcare sector in United States, and Grid #2,485 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Allogene Therapeutics, Inc. | 44.32 | 39 | 42 | 31 | 48 | 62 |
| ARS Pharmaceuticals, Inc. | 27.49 | 2 | 46 | 25 | 8 | 56 |
| TRex Bio, Inc. | 49.54 | 0 | 28 | 77 | 81 | 61 |
| Altimmune, Inc. | 42.70 | 40 | 42 | 22 | 57 | 52 |
| Eikon Therapeutics, Inc. | 38.23 | 41 | 26 | 37 | 29 | 59 |
| Strata Critical Medical, Inc. | 55.78 | 34 | 68 | 61 | 71 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.98 |
| P/B ratio | 1.04 |
EEarnings
| Trailing EPS | ₹-62.51 |
| Forward EPS | ₹-58.45 |
NNitro
| Price | 124.08 |
| 52-week high | 422.43 |
| 52-week low | 98.50 |
| Fall from 52-week high | 70.6% |
TTorque
| Return on equity (ROE) | -42.39% |
| Debt-to-equity | 0.18 |
AAnchor
| Beta (price swings) | 0.56 |
| Market cap | ₹4,286 Cr |
| Insider holding | 11.03% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Allogene Therapeutics, Inc.'s PosiPenta score?
Allogene Therapeutics, Inc.'s PosiPenta is 44.32 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Allogene Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Allogene Therapeutics, Inc. is Grid #401 of 837 in the Healthcare sector in United States, and Grid #2,485 of 4,000 in United States.
Which PosiPenta pillar is strongest for Allogene Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 62 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Allogene Therapeutics, Inc.?
Nitro (momentum), with a score of 31 out of 100: weaker than most similar companies.
Has Allogene Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.51 points, from 40.81 to 44.32.
PositoAI is for research and education only and is not investment advice.